chronic lymphocytic leukemia (CLL)
Chronic Lymphocytic Leukemia
... with chronic lymphocytic ...of chronic lymphocytic leukemia (the arrows point to the cluster of granules in the cells), and Panel D shows the cells of prolymphocytic leukemia, ...
44
Severe immune thrombocytopenia in chronic lymphocytic leukemia (CLL)
... The mechanisms underlying immune thrombocytopenia in chronic lymphocytic leukemia are still unclear. It has been estimated that ITP can complicate the course of CLL in approximately 2% of patients ...
5
Biological Prognostic Markers in Chronic Lymphocytic Leukemia
... Chronic lymphocytic leukemia (CLL) is the most pre- valent leukemic disorder of adult Euro-American popula- tion. It is characterized by the clonal proliferation and accumulation of morphologically ...
6
The spectrum of use of rituximab in chronic lymphocytic leukemia
... B-chronic lymphocytic leukemia (B-CLL): experience on safety and efficacy within a randomised multicenter phase III trial of the French Cooperative Group on CLL and WM (FCGCLL/MW) and the “Groupe ...
20
Role of bendamustine in the treatment of chronic lymphocytic leukemia
... with chronic lymphocytic leukemia (CLL) include an enhanced ability to make an accurate diagnosis and defi ne clinically meaningful prognostic groups, while improving outcome through more effective ...
8
Fludarabine in the treatment of chronic lymphocytic leukemia: a review
... Abstract: Fludarabine (FAMP) is the most effective and most extensively studied purine analog in indolent B-cell malignancies. Its use is indicated for fi rst- and second-line treatment of B-cell chronic ...
22
Recent Achievements in the Treatment of Chronic Lymphocytic Leukemia
... Current treatment approaches in chronic lymphocytic leukemia include alkylating agents, purine nucleoside analogs and monoclonal antibodies (mAb).Recently, several new agents have been explored and ...
12
Role of ofatumumab in treatment of chronic lymphocytic leukemia
... of chronic lymphocytic leukemia (CLL) has dramatically improved in the past decade with the addition of anti-CD20 monoclonal antibodies to the treatment ...ofatumumab, chronic ...
7
Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL).
... Chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) are the most common leukemias of the elderly (>43 year). However, the sequential occurrence of CML followed by ...
5
Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma
... from chronic lymphocytic leukemia/small lym- phocytic lymphoma (CLL/SLL) into an aggressive form of non-Hodgkin lymphoma (NHL), most commonly into diffuse large B cell lymphoma (DLBCL), particularly ...
7
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
... advanced chronic lymphocytic leukemia (CLL): re- sults of a planned interim analysis of the CLL10 trial, an international, randomized study of the German CLL Study Group ...with chronic lym- ...
13
The Danish National Chronic Lymphocytic Leukemia Registry
... Acute Leukemia Registry, and The Danish National Myeloma ...National Chronic Lymphocytic Leukemia Registry was founded within the Danish National Hematology ...with chronic lympho- ...
5
Telomere status in chronic lymphocytic leukemia with TP53 disruption
... In chronic lymphocytic leukemia (CLL), telomere dysfunction is associated with poor outcomes. TP53 is involved in cellular responses to dysfunctional telomeres, and its inactivation is the strongest ...
10
CD23 antigen regulation and signaling in chronic lymphocytic leukemia
... with chronic lymphocytic leukemia (B-CLLs), strongly express the CD23 antigen, a surface marker with significant prognostic importance in this ...
11
Refractory chronic lymphocytic leukemia – new therapeutic strategies
... Treatment outcome of chronic lymphocytic leukemia (CLL) has considerably improved since the introduction of fludarabine (F) as part of the standard therapy. Nevertheless, refractoriness to ...
11
CHIMERIC ANTIGEN RECEPTOR FOR CHRONIC LYMPHOCYTIC LEUKEMIA A REVIEW
... Chronic lymphocytic leukemia (CLL) cancer is a deadly one which affects the bone marrow from making it to produce more amounts of white blood cells in the humans ...
6
Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
... Abstract: Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in Western countries. Fludarabine-based regimens demonstrate higher response rates in younger patients but ...
11
The genomic landscape of chronic lymphocytic leukemia: clinical implications
... Chronic lymphocytic leukemia (CLL) is a clonal neopla- sia of B-lymphocytes which accumulate mainly in the blood, bone marrow, lymph nodes and spleen ...
8
Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia
... RIP140 is a transcriptional coregulator, (also known as NRIP1), which finely tunes the activity of various transcription factors and plays very important physiological roles. Noticeably, the RIP140 gene has been ...
6
Characteristics of chronic lymphocytic leukemia in Senegal
... Chronic lymphocytic leukemia (CLL) is the most frequent form of leukemia in Western countries [1, ...threatening leukemia or as an indolent form ...
8